What are the opening hours?

Monday 9:30am - 5:30pm Tuesday 9:30am - 5:30pm Wednesday 9:30am - 5:30pm Thursday 9:30am - 5:30pm Friday 9:30am - 5:30pm

Cancer Research & Treatment Fund, Inc.

Home
United States
New York, NY
Cancer Research & Treatment Fund, Inc.

The official page of Cancer Research & Treatment Fund. Please follow us to receive our latest news. In 2012, CR&T began funding the Richard T. Silver.

The Cancer Research and Treatment Fund (CR&T) is a driving force in cancer research and treatment. Founded in 1968, we are a not-for-profit fund that is committed to the belief that advances in blood cancer research lead to important breakthroughs, and a better understanding of the biology and treatment of all forms of cancer. In 2000, CR&T and the generosity of donors were instrumental in the establishment of the Center for the Study of Leukemia and Myeloproliferative Neoplasms at Weill Cornell Medical College, a leading institution for cancer research. More recently, we have been involved with the breakthrough discoveries of Gleevec and now the JAK2 enzyme cancer marker . Silver Myeloproliferative Neoplasm Center at Weil Cornell Medical College, the successor to the Center for the Study of Leukemia and Myelproliferative Neoplasms at Weill Cornel Medical College. The center was dedicated in a special ceremony on February 18, 2014, and will serve as a translational research and treatment center, engaging in cutting edge discoveries surrounding MPNs. CR&T played a pivotal role in establishing the Silver MPN Center. In addition to contributing a $3.7 million gift, the Center is named after CR&T’s founder, Dr. Richard T. Dr. Andrew Schaefer, former Chairman of the Department of Medicine at Weill Cornell Medical College, has been appointed as the Center’s Director. We have achieved these successes by aggressively pursuing biological, pharmacological and molecular solutions to understand cancer, and to design drugs and diagnostic tools based on new knowledge—providing critical resources for a multidisciplinary approach that offers the greatest promise against all forms of cancer. For more than three decades, CR&T has been a major source of financial support for researchers on the frontlines of clinical cancer research at Weill Medical College of Cornell University, located at New York-Presbyterian Hospital. We have also awarded grants for research at Johns Hopkins University Medical Center, MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center.

08/20/2025

Living with a Myeloproliferative Neoplasm (MPN) can bring many challenges, but eating a balanced, nutritious diet can be a powerful ally in your journey. Here are a few tips to help support your body while undergoing treatment.

08/18/2025

Blood cancers like leukemia, lymphoma, and myeloma affect millions worldwide, but thanks to groundbreaking research, we're seeing real progress in the fight. Every breakthrough brings us one step closer to better treatments, earlier diagnoses, and ultimately, a cure.

But we can't stop now — research is the key to unlocking new hope for patients and families battling these diseases. Let's continue to support and fund the scientists, doctors, and organizations dedicated to improving lives. Together, we can make a difference. 💪❤️

08/14/2025

Every year, thousands of lives are affected by blood cancers like leukemia, lymphoma, and myeloma. Early detection, research, and support can make a world of difference for those battling these diseases.

This month, let's come together to spread awareness, support research, and show solidarity with those fighting these cancers. Whether through education, donating, or simply sharing this post, you can make a difference.

08/12/2025

Mark Your Calendar for CR&T’s Signature Events! We’re excited to announce three major events this season that bring together patients, caregivers, physicians, and researchers in the fight against blood cancers:

✨ Cancer Survivors Hall of Fame Dinner
Join us at the elegant Essex House in NYC as we honor inspiring survivors and the groundbreaking research that gave them a second chance.
📍 Fall 2025 – Essex House, New York City
Learn more: https://www.crt.org/hall-of-fame-event

🧬 International Patient Symposium on Myeloproliferative Neoplasms (MPNs)
Empowering patients with the latest research and treatment insights, this symposium offers direct access to leading experts in MPNs.
📍 Fall 2025 – Belfer Research Building, Weill Cornell Medicine, NYC
Learn more: https://www.crt.org/patient-symposium-on-mpns/

📚 International Congress on MPNs
While not hosted by CR&T, this professional education event is a vital opportunity for patients and providers alike. Special thanks to Melton Medical Educational for offering a discount to CR&T Symposium attendees.
📍 Fall 2025 – New York Marriott at the Brooklyn Bridge
Learn more: https://www.crt.org/international-congress/

Together, we learn. Together, we honor. Together, we advance the cure.

08/11/2025

We couldn’t do this without you.Thanks to the generosity of our donors, CR&T-supported researchers are making real progress in targeted therapies for blood cancers. Every dollar helps bring us closer to a cure.

From all of us—thank you. Give today: crt.org/donate

08/05/2025

Did you know? Blood cancers like leukemia, lymphoma, and myeloma affect over 1.3 million people in the U.S. alone.

At CR&T, we’re funding life-saving research to unlock new treatments and support patients in their fight.

🔬 Join us in advancing science.
💙 Learn more: www.crt.org

07/23/2025

CR&T recently approved the 2nd year of funding of a 2 year grant to Despina Siolas, MD, PhD. Her work is truly impactful and we are proud to support her research!

💙

07/16/2025

Living with an MPN? Here are daily wellness tips that can help:

🌿 Stay active (gentle walks count!)
🥗 Eat whole, anti-inflammatory foods
🧘 Manage stress with mindfulness
👩 ⚕ Keep regular check-ins with your care team

06/24/2025

Behind every patient is someone who listens, supports, and loves. 💛

Let's celebrate caregivers — the unsung heroes of every MPN journey.

Tag a caregiver you admire.

06/13/2025

MPN Fact Friday

Fact: Most MPNs are chronic conditions, but advances in research are helping patients live longer, fuller lives.

Share to raise awareness!

06/11/2025

Your donation = Hope.

💰 Every dollar funds life-saving research into treatments for MPNs and other blood cancers.
This month, help us move one step closer to a cure.

👉 Donate today: https://www.crt.org/donate/

05/14/2025

At CR&T, we’re committed to funding research that leads to better treatments and, ultimately, cures for blood cancers. Your donation helps fund life-saving research into myeloproliferative neoplasms (MPNs) and other cancers, giving patients and families the hope they deserve.

Be a part of the solution. Every donation, no matter the size, brings us one step closer to a world without blood cancer. 💪

🔹 Donate now: https://www.crt.org/donate/

&T

Address

500 E 77th St, Ste 1001
New York, NY
10162

Opening Hours

Monday	9:30am - 5:30pm
Tuesday	9:30am - 5:30pm
Wednesday	9:30am - 5:30pm
Thursday	9:30am - 5:30pm
Friday	9:30am - 5:30pm

Website

http://www.crt.org/

Alerts

Be the first to know and let us send you an email when Cancer Research & Treatment Fund, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cancer Research & Treatment Fund, Inc.:

Shortcuts

Featured

Magnus Wellness
16 E 40th Street, Fl 4

Want your practice to be the top-listed Clinic in New York?

Our Story

The Cancer Research and Treatment Fund (CR&T) is a driving force in cancer research and treatment. Founded in 1968, we are a not-for-profit fund that is committed to the belief that advances in blood cancer research lead to important breakthroughs, and a better understanding of the biology and treatment of all forms of cancer. In 2000, CR&T and the generosity of donors were instrumental in the establishment of the Center for the Study of Leukemia and Myeloproliferative Neoplasms at Weill Cornell Medical College, a leading institution for cancer research. More recently, we have been involved with the breakthrough discoveries of Gleevec and now the JAK2 enzyme cancer marker . In 2012, CR&T began funding the Richard T. Silver Myeloproliferative Neoplasm Center at Weil Cornell Medical College, the successor to the Center for the Study of Leukemia and Myelproliferative Neoplasms at Weill Cornell Medical College. The center was dedicated in a special ceremony on February 18, 2014, and serves as a translational research and treatment center, engaging in cutting edge discoveries surrounding MPNs. CR&T played a pivotal role in establishing the Silver MPN Center. In addition to contributing a $3.7 million gift, the Center is named after CR&T’s founder, Dr. Richard T. Silver. Dr. Andrew Schafer, former Chairman of the Department of Medicine at Weill Cornell Medical College, has been appointed as the Center’s Director. We have achieved these successes by aggressively pursuing biological, pharmacological and molecular solutions to understand cancer, and to design drugs and diagnostic tools based on new knowledge—providing critical resources for a multidisciplinary approach that offers the greatest promise against all forms of cancer. CR&T will mark its 50th Anniversary in 2018. For nearly 50 years, the organization has been a major source of financial support for researchers on the frontlines of clinical cancer research at Weill Medical College of Cornell University, located at New York-Presbyterian Hospital. We have also awarded grants for research at Johns Hopkins University Medical Center, MD Anderson Cancer Center, and Memorial Sloan-Kettering Cancer Center.